OS18 - 10.a.4 Results of the 2016 AND 2017 proficiency testing schemes for FM...EuFMD
Similar to OS20 - Validation of recombinant protein-based ELISA for detection of antibodies to foot-and-mouth disease virus Type-O - Dr. Eun-Jin Choi (20)
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
OS20 - Validation of recombinant protein-based ELISA for detection of antibodies to foot-and-mouth disease virus Type-O - Dr. Eun-Jin Choi
1. 1EuFMD | Open Session special edition | #OS20se
National Animal and Plant Quarantine Agency / Republic of Korea
VALIDATION OF RECOMBINANT
PROTEIN-BASED ELISA FOR DETECTION
OF ANTIBODIES TO FOOT-AND-MOUTH
DISEASE VIRUS TYPE-O
Eun-Jin Choi (Presenter), YouJin Han, JiHyun Lee, Hyun Mi Pyo,
Doheon Gwon, Wonseok Shin, JaeMyoung Kim and Mi-Young Park
2. 2EuFMD | Open Session special edition | #OS20se
The ELISA (r-SPCE) kit has been developed and validated with
field sera collected from either vaccinated or non-vaccinated
from non-infected cattle and pig farms, international reference
sera obtained from WRLFMD, Pirbright and sera from
experimentally challenged animals.
The recombinant protein (rP13C) was derived from
recombinant VP4231 protein of FMDV O/JC/SKR/2014
(O/SEA/Mya98) genes using a baculovirus-expressed system.
Main Idea
3. 3EuFMD | Open Session special edition | #OS20se
The overall diagnostic specificity of 99.9% with a threshold of 50%
inhibition was identified by analyzing 1,070 cattle and 730 pigs from
FMD-free and non-vaccinated country (Canada, USA).
Diagnostic sensitivity estimated using 475 known positive animal sera
result of 95.2%.
International reference sera were correctly detected.
A high level of serotype-specificity was demonstrated testing
IAEA/FAO standard sera strongly positive against other FMDV
serotypes.
Also, the CV obtained for evaluating reproducibility and repeatability
estimated ≤10%, demonstrating the excellent stability of the ELISA (r-
SPCE).
4. 4EuFMD | Open Session special edition | #OS20se
Objectives
- A new recombinant protein-based solid-phase competitive ELISA(r-
SPCE) with monoclonal antibody (Mab) for detection of antibodies to
FMDV type-O and has been developed and validated with field sera
and international reference sera.
Outcomes
- The recombinant protein-based SPCE developed for the detection of
antibodies to FMDV type-O demonstrated high specificity and
sensitivity. In addition, this assay offers advantages in terms of
repeatability and broader cross-specificity, but also is easy-to use
and applicable to multiple species.